Literature DB >> 4026411

IgG monoclonal gammopathy in four patients with polymyalgia rheumatica.

D Ilfeld, J Barzilay, D Vana, M Ben-Bassat, H Joshua, I Pick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4026411      PMCID： PMC1001685          DOI： 10.1136/ard.44.7.501

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  3 in total

1.  Immunoglobulins in temporal arteries. An immunofluorescent study.

Authors:  G C Liang; P A Simkin; M Mannik
Journal:  Ann Intern Med       Date:  1974-07       Impact factor: 25.391

2.  Hepatitis-B antibody in polymyalgia Rheumatica.

Authors:  P A Bacon; S M Doherty; A J Zuckerman
Journal:  Lancet       Date:  1975-09-13       Impact factor: 79.321

3.  Immunological and histological study of temporal arteries.

Authors:  J R Park; B L Hazleman
Journal:  Ann Rheum Dis       Date:  1978-06       Impact factor: 19.103
  3 in total
  3 in total

Review 1.  Giant cell arteritis and polymyalgia rheumatica: pathophysiology and management.

Authors:  Miguel A Gonzalez-Gay; Carlos Garcia-Porrua; Jose A Miranda-Filloy; Javier Martin
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

2.  Polymyalgia rheumatica, temporal arteritis and malignancy.

Authors:  E P Das-Gupta; P Bandyopadhyay; J L Shun; J P Ng
Journal:  Postgrad Med J       Date:  1996-05       Impact factor: 2.401

3.  Rheumatologic diseases impact the risk of progression of MGUS to overt multiple myeloma.

Authors:  Normann Steiner; Georg Göbel; Daniela Michaeler; Anna-Luise Platz; Wolfgang Prokop; Anna Maria Wolf; Dominik Wolf; Christina Duftner; Eberhard Gunsilius
Journal:  Blood Adv       Date:  2021-03-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.